Health Risk Factor Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chinese University of Hong Kong
Numerous gene mutations in retinitis pigmentosa challenge gene therapy design
March 22nd, 2005
Numerous gene mutations in retinitis pigmentosa challenge gene therapy design. According to a study from the Peoples Republic of China, "retinitis pigmentosa (RP) is a group of inherited progressive retinal diseases affecting about 1 in 3500 people worldwide. So far, there is no prevention or cure, with permanent visual loss or even blindness the ultimate consequence usually after midlife. The genetics of RP are complex." "It can be sporadic, autosomal dominant, autosomal recessive, or X-linked. Thirty-two genes are known to be associated with RP, sometimes the same gene gets involved in different inheritance traits. Some RP cases have a digenic...
Source: Health Risk Factor Week (2005-03-22)
|
